SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo

por Zhang, Qiu-Yang, Tao, Shu-Ya, Lu, Chang, Li, Jing-Jing, Li, Xiu-Miao, Yao, Jin, Jiang, Qin, Yan, Biao
Publicado 2020